Cas:1243541-83-4 9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl- manufacturer & supplier

We serve Chemical Name:9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl- CAS:1243541-83-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

9H-Carbazole, 3,3'-(1,6-pyrenediyl)bis[9-phenyl-

Chemical Name:9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl-
CAS.NO:1243541-83-4
Synonyms:9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl-
Molecular Formula:C52H32N2
Molecular Weight:684.82388
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl- Use and application,9H-Carbazole, 3,3′-(1,6-pyrenediyl)bis[9-phenyl- technical grade,usp/ep/jp grade.


Related News: In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 1-Benzyloxy-4-methyl-cyclohex-3-enecarbonyl chloride manufacturers As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. Cyclohexanol, 1-butyl-2-(phenylmethylene)-, (E)- suppliers In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April. 1H-Indole-4-methanol, 1,3-dimethyl-2-(methylthio)- vendor & factory.